Metastatic Crohn’s disease: Remission induced by mesalamine and prednisone - 07/09/11
Doi : 10.1016/S0190-9622(99)70125-8
Abstract |
We describe a patient with cutaneous Crohn’s disease with extensive cutaneous ulcerations preceding the diagnosis of gastrointestinal Crohn’s. The cutaneous lesions responded to mesalamine and prednisone. The patient has been maintained on a regimen of mesalamine alone without recurrence. We discuss available forms of mesalamine and their function in cutaneous disease. (J Am Acad Dermatol 1999;41:476-9.)
Le texte complet de cet article est disponible en PDF.Plan
 | From the Departments of Dermatologya and Gastroenterology,b Wilford Hall Medical Center/Brooke Army Medical Center, San Antonio, Texas. |
| The opinions and assertions contained herein are the private views of the authors and not to be construed as official or reflecting the policies of the US Air Force, US Army, or the Department of Defense. |
 | Reprint requests: Robert Gilson, Major, USAF, MC, PSC 78, Box 2969, APO AP 96326. |
| 16/54/99374 |
© 1999
American Academy of Dermatology, Inc. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 41 - N° 3
P. 476-479 - septembre 1999 Retour au numéro
Article précédent
- Adverse cutaneous reactions to ticlopidine in patients with coronary stents
- Gil Yosipovitch, Eldad Rechavia, Maora Feinmesser, Michael David
- Anetoderma of prematurity in association with electrocardiographic electrodes
- Paul B. Colditz, Kimble R. Dunster, Gloria J. Joy, Ivan M. Robertson
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?